Coverage
-
August 26, 2011
Teva Pharmaceuticals agreed to drop its patent infringement claims against Apotex Corp. in Florida federal court on Thursday, ending the short-lived battle over a generic version of Parkinson's disease drug Azilect.
1 other articles on this case.
View all »